487 articles in this topic
Lactobacillus johnsonii bacteria enhances immune response and prevents liver cancer recurrence when combined with immunotherapy.
New research reveals how nasopharyngeal cancer cells rewire their metabolism to survive chemotherapy, pointing to potential treatment strategies.
New research reveals how breast cancer cells exploit fatty acids in lung tissue to enhance survival and metastasis.
New research reveals how a common gut bacterium reprograms immune cells to accelerate colorectal cancer progression.
Scientists discover LRRC15 protein controls cancer-promoting cells, offering new therapeutic approach for lung cancer patients.
Researchers found cancer cells use JAK1 protein to survive radiation therapy, but targeting KIF18A protein can overcome this resistance.
New research reveals how deadly thyroid cancer reprograms itself to escape natural killer cells, opening doors for better treatments.
New research reveals how osteosarcoma cells manipulate RNA stability to maintain aggressive growth and resist chemotherapy.
Study expands treatment options by demonstrating olaparib effectiveness in patients with PALB2 and somatic BRCA mutations.
Major trial reveals blood clot risks vary significantly between different pancreatic cancer treatment approaches.
Oncologists still lack clear guidance on optimal capecitabine dosing, highlighting broader issues in cancer treatment precision.
New circulating tumor DNA test identifies high-risk colon cancer patients with 80% accuracy, potentially revolutionizing treatment decisions.
